Klinik und Poliklinik für Neurologie

Publikationen 2014

van der Zee J, Van Langenhove T, Kovacs GG, Dillen L, Deschamps W, Engelborghs S, Mat?j R, Vandenbulcke M, Sieben A, Dermaut B, Smets K, Van Damme P, Merlin C, Laureys A, Van Den Broeck M, Mattheijssens M, Peeters K, Benussi L, Binetti G, Ghidoni R, Borroni B, Padovani A, Archetti S, Pastor P, Razquin C, Ortega-Cubero S, Hernández I, Boada M, Ruiz A, de Mendonça A, Miltenberger-Miltényi G, do Couto FS, Sorbi S, Nacmias B, Bagnoli S, Graff C, Chiang HH, Thonberg H, Perneczky R, Diehl- Schmid J, Alexopoulos P, Frisoni GB, Bonvicini C, Synofzik M, Maetzler W, vom Hagen JM, Schöls L, Haack TB, Strom TM, Prokisch H, Dols-Icardo O, Clarimón J, Lleó A, Santana I, Almeida MR, Santiago B, Heneka MT, Jessen F, Ramirez A, Ramirez A, Sanchez-Valle R, Llado A, Gelpi E, Sarafov S, Tournev I, Jordanova A, Parobkova E, Fabrizi GM, Testi S, Salmon E, Ströbel T, Santens P, Robberecht W, De Jonghe P, Martin JJ, Cras P, Vandenberghe R, De Deyn PP, Cruts M, Sleegers K, Van Broeckhoven C. Rare mutations in SQSTM1 modify susceptibility to frontotemporal lobar degeneration. Acta Neuropathol (Berl). 2014;128(3): 397-410 (Impact(2014)=10.762, Typ=Journal Article; Research Support, Non-U.S. Gov't; Article)

Malhotra A, Younesi E, Gündel M, Müller B, Heneka MT, Hofmann-Apitius M. ADO: a disease ontology representing the domain knowledge specific to Alzheimer's disease. Alzheimers Dement. 2014;10(2): 238-46 (Impact(2014)=12.407, Typ=Journal Article; Research Support, Non-U.S. Gov't; Article)

Peter J, Scheef L, Abdulkadir A, Boecker H, Heneka M, Wagner M, Koppara A, Klöppel S, Jessen F, Alzheimer's Disease Neuroimaging Initiative. Gray matter atrophy pattern in elderly with subjective memory impairment. Alzheimers Dement. 2014;10(1): 99-108 (Impact(2014)=12.407, Typ=Journal Article; Research Support, Non-U.S. Gov't; Article)

Kummer MP, Heneka MT. Truncated and modified amyloid-beta species. Alzheimers Res Ther. 2014;6(3): 28 (Impact(2014)=3.979, Typ=Journal Article; Review; Review)

Malfatti E, Nilsson J, Hedberg-Oldfors C, Hernandez-Lain A, Michel F, Dominguez-Gonzalez C, Viennet G, Akman HO, Kornblum C, Van den Bergh P, Romero NB, Engel AG, DiMauro S, Oldfors A. A new muscle glycogen storage disease associated with glycogenin-1 deficiency. Ann Neurol. 2014;76(6): 891-8 (Impact (2014)=9.977, Typ=Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural; Article)

Glebov K, Voronezhskaya EE, Khabarova MY, Ivashkin E, Nezlin LP, Ponimaskin EG. Mechanisms underlying dual effects of serotonin during development of Helisoma trivolvis (Mollusca). BMC Dev Biol. 2014;14: 14 (Impact(2014)=2.667, Typ=Journal Article; Research Support, Non-U.S. Gov't; Article)

Upadhaya AR, Kosterin I, Kumar S, von Arnim CAF, Yamaguchi H, Fandrich M, Walter J, Thal DR. Biochemical stages of amyloid-beta peptide aggregation and accumulation in the human brain and their association with symptomatic and pathologically preclinical Alzheimer's disease Brain. 2014;137: 887-903 (Impact (2014)=9.196, Typ=Article)

du Montcel ST, Durr A, Bauer P, Figueroa KP, Ichikawa Y, Brussino A, Forlani S, Rakowicz M, Schols L, Mariotti C, van de Warrenburg BPC, Orsi L, Giunti P, Filla A, Szymanski S, Klockgether T, Berciano J, Pandolfo M, Boesch S, Melegh B, Timmann D, Mandich P, Camuzat A, Goto J, Ashizawa T, Cazeneuve C, Tsuji S, Pulst SM, Brusco A, Riess O, Brice A, Stevanin G, Clin Res Consortium , EUROSCA Network. Modulation of the age at onset in spinocerebellar ataxia by CAG tracts in various genes Brain. 2014;137: 2444-2455 (Impact(2014)=9.196, Typ=Article)

Prajeeth CK, Löhr K, Floess S, Zimmermann J, Ulrich R, Gudi V, Beineke A, Baumgärtner W, Müller M, Huehn J, Stangel M. Effector molecules released by Th1 but not Th17 cells drive an M1 response in microglia. Brain Behav Immun. 2014;37: 248-59 (Impact(2014)=5.889, Typ=Journal Article; Research Support, Non-U.S. Gov't; Article)

van Echten-Deckert G, Hagen-Euteneuer N, Karaca I, Walter J. Sphingosine-1-phosphate: boon and bane for the brain. Cell Physiol Biochem. 2014;34 (1): 148-57 (Impact(2014)=2.875, Typ=Journal Article; Review; Research Support, Non-U.S. Gov't; Review)

Ganos C, Zittel S, Minnerop M, Schunke O, Heinbokel C, Gerloff C, Zühlke C, Bauer P, Klockgether T, Münchau A, Bäumer T. Clinical and neurophysiological profile of four German families with spinocerebellar ataxia type 14. Cerebellum. 2014;13(1): 89-96 (Impact(2014)=2.717, Typ=Journal Article; Research Support, Non-U.S. Gov't; Article)

Kaut O, Jacobi H, Coch C, Prochnicki A, Minnerop M, Klockgether T, Wüllner U. A randomized pilot study of stochastic vibration therapy in spinocerebellar ataxia. Cerebellum. 2014;13(2): 237-42 (Impact(2014)=2.717, Typ=Journal Article; Research Support, Non-U.S. Gov't; Article)

Sieb JP. Myasthenia gravis: an update for the clinician. Clin Exp Immunol. 2014;175(3): 408-18 (Impact(2014)=3.037, Typ=Journal Article; Review; Review)

Elbracht M, Senderek J, Schara U, Nolte K, Klopstock T, Roos A, Reimann J, Zerres K, Weis J, Rudnik-Schöneborn S. Clinical and morphological variability of the E396K mutation in the neurofilament light chain gene in patients with Charcot-Marie- Tooth disease type 2E. Clin Neuropathol. 2014;33(5): 335-43 (Impact (2014)=1.528, Typ=Journal Article; Research Support, Non-U.S. Gov't; Article)

Nelles M, Greschus S, Möhlenbruch M, Simon B, Wüllner U, Urbach H. Patient selection for mechanical thrombectomy. Clin Neuroradiol. 2014;24(3): 239-44 (Impact(2014)=2.25, Typ=Article; Journal Article; Article)

Kaut O, Ramirez A, Ramirez A, Pieper H, Schmitt I, Jessen F, Wüllner U. DNA methylation of the TNF-? promoter region in peripheral blood monocytes and the cortex of human Alzheimer's disease patients. Dement Geriatr Cogn Disord. 2014;38(1-2): 10-5 (Impact(2014)=3.547, Typ=Journal Article; Research Support, Non-U.S. Gov't; Article)

Dressler D, Kupsch A, Seitzinger A, Paus S. The dystonia discomfort scale (DDS): a novel instrument to monitor the temporal profile of botulinum toxin therapy in cervical dystonia. Eur J Neurol. 2014;21(3): 459-62 (Impact(2014)=4.055, Typ=Journal Article; Clinical Trial; Multicenter Study; Research Support, Non-U.S. Gov't; Article)

van de Warrenburg BP, van Gaalen J, Boesch S, Burgunder JM, Dürr A, Giunti P, Klockgether T, Mariotti C, Pandolfo M, Riess O. EFNS/ENS Consensus on the diagnosis and management of chronic ataxias in adulthood. Eur J Neurol. 2014;21(4): 552-62 (Impact(2014)=4.055, Typ=Journal Article; Article)

Pradier B, Jeub M, Markert A, Mauer D, Tolksdorf K, Van de Putte T, Seuntjens E, Gailus-Durner V, Fuchs H, Hrab? de Angelis M, Huylebroeck D, Beck H, Zimmer A, Rácz I. Smad-interacting protein 1 affects acute and tonic, but not chronic pain. Eur J Pain. 2014;18(2): 249-57 (Impact(2014)=2.928, Typ=Journal Article; Research Support, Non-U.S. Gov't; Article)

Stoffels B, Hupa KJ, Snoek SA, van Bree S, Stein K, Schwandt T, Vilz TO, Lysson M, Veer CV, Kummer MP, Hornung V, Kalff JC, de Jonge WJ, Wehner S. Postoperative ileus involves interleukin-1 receptor signaling in enteric glia. Gastroenterology. 2014;146(1): 176-87.e1 (Impact(2014)=16.716, Typ=Journal Article; Research Support, Non-U.S. Gov't; Article)

Nicholls TJ, Zsurka G, Peeva V, Schöler S, Szczesny RJ, Cysewski D, Reyes A, Kornblum C, Sciacco M, Moggio M, Dziembowski A, Kunz WS, Minczuk M. Linear mtDNA fragments and unusual mtDNA rearrangements associated with pathological deficiency of MGME1 exonuclease. Hum Mol Genet. 2014;23(23): 6147-62 (Impact (2014)=6.393, Typ=Journal Article; Research Support, Non-U.S. Gov't; Article)

Ramirez A, Ramirez A, van der Flier WM, Herold C, Ramonet D, Heilmann S, Lewczuk P, Popp J, Lacour A, Drichel D, Louwersheimer E, Kummer MP, Cruchaga C, Hoffmann P, Teunissen C, Holstege H, Kornhuber J, Peters O, Naj AC, Chouraki V, Bellenguez C, Gerrish A, International Genomics of Alzheimer's Project (IGAP) , Alzheimer's Disease Neuroimaging Initiative (ADNI) , Heun R, Frölich L, Hüll M, Buscemi L, Herms S, Kölsch H, Scheltens P, Breteler MM, Rüther E, Wiltfang J, Goate A, Jessen F, Maier W, Heneka MT, Becker T, Nöthen MM. SUCLG2 identified as both a determinator of CSF A?1-42 levels and an attenuator of cognitive decline in Alzheimer's disease. Hum Mol Genet. 2014;23(24): 6644-58 (Impact(2014)=6.393, Typ=Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.; Article)

Rezaei-Ghaleh N, Amininasab M, Giller K, Kumar S, Stündl A, Schneider A, Becker S, Walter J, Zweckstetter M. Turn plasticity distinguishes different modes of amyloid-? aggregation. J Am Chem Soc. 2014;136(13): 4913-9 (Impact(2014)=12.113, Typ=Journal Article; Research Support, Non-U.S. Gov't; Article)

Karaca I, Tamboli IY, Glebov K, Richter J, Fell LH, Grimm MO, Haupenthal VJ, Hartmann T, Gräler MH, van Echten-Deckert G, Walter J. Deficiency of sphingosine-1-phosphate lyase impairs lysosomal metabolism of the amyloid precursor protein. J Biol Chem. 2014;289(24): 16761-72 (Impact(2014)=4.573, Typ=Journal Article; Research Support, Non-U.S. Gov't; Article)

Oynhausen S, Alcauskas M, Hannigan C, Bencosme Y, Müller M, Lublin F, Krieger S. Emergency medical care of multiple sclerosis patients: primary data from the mount sinai resource utilization in multiple sclerosis project. J Clin Neurol. 2014;10(3): 216-21 (Impact(2014)=1.7, Typ=Journal Article; Article)

Jung S, Zaremba S, Heisig A, Eikermann M. Elevated body position early after delivery increased airway size during wakefulness, and decreased apnea hypopnea index in a woman with pregnancy related sleep apnea. J Clin Sleep Med. 2014;10(7): 815-7 (Impact(2014)=3.053, Typ=Journal Article; Article)

Heneka MT. Macrophages derived from infiltrating monocytes mediate autoimmune myelin destruction. J Exp Med. 2014;211(8): 1500 (Impact (2014)=12.515, Typ=Journal Article; Comment; Editorial)

du Montcel ST, Durr A, Rakowicz M, Nanetti L, Charles P, Sulek A, Mariotti C, Rola R, Schols L, Bauer P, Dufaure-Gare I, Jacobi H, Forlani S, Schmitz-Hubsch T, Filla A, Timmann D, van de Warrenburg BP, Marelli C, Kang JS, Giunti P, Cook A, Baliko L, Bela M, Boesch S, Szymanski S, Berciano J, Infante J, Buerk K, Masciullo M, Di Fabio R, Depondt C, Ratka S, Stevanin G, Klockgether T, Brice A, Golmard JL. Prediction of the age at onset in spinocerebellar ataxia type 1, 2, 3 and 6 J Med Genet. 2014;51(7): 479- 486 (Impact(2014)=6.335, Typ=Article)

Krauthausen M, Saxe S, Zimmermann J, Emrich M, Heneka MT, Müller M. CXCR3 modulates glial accumulation and activation in cuprizone-induced demyelination of the central nervous system. J Neuroinflammation. 2014;11: 109 (Impact(2014)=5.408, Typ=Journal Article; Research Support, Non-U.S. Gov't; Article)

Edan G, Kappos L, Montalbán X, Polman CH, Freedman MS, Hartung HP, Miller D, Barkhof F, Herrmann J, Lanius V, Stemper B, Pohl C, Sandbrink R, Pleimes D, BENEFIT Study Group. Long-term impact of interferon beta-1b in patients with CIS: 8-year follow-up of BENEFIT. J Neurol Neurosurg Psychiatry. 2014;85(11): 1183-9 (Impact(2014)=6.807, Typ=Journal Article; Randomized Controlled Trial; Multicenter Study; Research Support, Non-U.S. Gov't; Article)

Flieger M, Ganswindt U, Schwarz SB, Kreth FW, Tonn JC, la Fougère C, Ertl L, Linn J, Herrlinger U, Belka C, Niyazi M. Re-irradiation and bevacizumab in recurrent high-grade glioma: an effective treatment option. J Neurooncol. 2014;117(2): 337-45 (Impact(2014)=3.07, Typ=Journal Article; Article)

Kummer MP, Hammerschmidt T, Martinez A, Terwel D, Eichele G, Witten A, Figura S, Stoll M, Schwartz S, Pape HC, Schultze JL, Weinshenker D, Heneka MT. Ear2 deletion causes early memory and learning deficits in APP/PS1 mice. J Neurosci. 2014;34(26): 8845-54 (Impact(2014)=6.344, Typ=Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural; Article)

Ascherio A, Munger KL, White R, Köchert K, Simon KC, Polman CH, Freedman MS, Hartung HP, Miller DH, Montalbán X, Edan G, Barkhof F, Pleimes D, Radü EW, Sandbrink R, Kappos L, Pohl C. Vitamin D as an early predictor of multiple sclerosis activity and progression. JAMA Neurol. 2014;71(3): 306-14 (Impact(2014)=7.271, Typ=Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural; Article)

Haghikia A, Langer-Gould A, Rellensmann G, Schneider H, Tenenbaum T, Elias-Hamp B, Menck S, Zimmermann J, Herbstritt S, Marziniak M, Kümpfel T, Meinl I, Plavina T, Gold R, Hellwig K. Natalizumab use during the third trimester of pregnancy. JAMA Neurol. 2014;71(7): 891-5 (Impact(2014)=7.271, Typ=Journal Article; Review; Case Reports; Research Support, Non-U.S. Gov't; Article)

Klockgether T. Spinocerebellar ataxia type 2: progression before diagnosis. Lancet Neurol. 2014;13(5): 445-6 (Impact(2014)=21.896, Typ=Journal Article; Comment; Editorial)

Widmann CN, Heneka MT. Long-term cerebral consequences of sepsis. Lancet Neurol. 2014;13(6): 630-6 (Impact(2014)=21.896, Typ=Journal Article; Research Support, Non-U.S. Gov't; Article)

Widmann CN, Schewe JC, Heneka MT. Sepsis-associated encephalopathy versus sepsis-induced encephalopathy-Authors' reply. Lancet Neurol. 2014;13(10): 968-9 (Impact(2014)=21.896, Typ=Letter; Letter)

Stupp R, Hegi ME, Gorlia T, Erridge SC, Perry J, Hong YK, Aldape KD, Lhermitte B, Pietsch T, Grujicic D, Steinbach JP, Wick W, Tarnawski R, Nam DH, Hau P, Weyerbrock A, Taphoorn MJ, Shen CC, Rao N, Thurzo L, Herrlinger U, Gupta T, Kortmann RD, Adamska K, McBain C, Brandes AA, Tonn JC, Schnell O, Wiegel T, Kim CY, Nabors LB, Reardon DA, van den Bent MJ, Hicking C, Markivskyy A, Picard M, Weller M, European Organisation for Research and Treatment of Cancer (EORTC) , Canadian Brain Tumor Consortium , CENTRIC study team. Cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma with methylated MGMT promoter (CENTRIC EORTC 26071-22072 study): a multicentre, randomised, open-label, phase 3 trial. Lancet Oncol. 2014;15(10): 1100-8 (Impact(2014)=24.69, Typ=Journal Article; Clinical Trial, Phase III; Randomized Controlled Trial; Multicenter Study; Research Support, Non-U.S. Gov't; Comparative Study; Article)

Gauthier-Kemper A, Igaev M, Sündermann F, Janning D, Brühmann J, Moschner K, Reyher HJ, Junge W, Glebov K, Walter J, Bakota L, Brandt R. Interplay between phosphorylation and palmitoylation mediates plasma membrane targeting and sorting of GAP43. Mol Biol Cell. 2014;25(21): 3284-99 (Impact(2014)=4.466, Typ=Journal Article; Research Support, Non-U.S. Gov't; Article)

Karabul N, Berndt J, Kornblum C, Kley RA, Wenninger S, Tiling N, Mengel E, Plöckinger U, Vorgerd M, Deschauer M, Schoser B, Hanisch F. Pregnancy and delivery in women with Pompe disease. Mol Genet Metab. 2014;112(2): 148-53 (Impact(2014)=2.625, Typ=Journal Article; Article)

Brosseron F, Krauthausen M, Kummer M, Heneka MT. Body fluid cytokine levels in mild cognitive impairment and Alzheimer's disease: a comparative overview. Mol Neurobiol. 2014;50(2): 534-44 (Impact(2014)=5.137, Typ=Journal Article; Research Support, Non-U.S. Gov't; Article)

Boesch S, Nachbauer W, Mariotti C, Sacca F, Filla A, Klockgether T, Klopstock T, Schöls L, Jacobi H, Büchner B, vom Hagen JM, Nanetti L, Manicom K. Safety and tolerability of carbamylated erythropoietin in Friedreich's ataxia. Mov Disord. 2014;29(7): 935-9 (Impact(2014)=5.68, Typ=Journal Article; Randomized Controlled Trial; Multicenter Study; Clinical Trial, Phase II; Research Support, Non-U.S. Gov't; Article)

Roeske S, Filla I, Heim S, Amunts K, Helmstaedter C, Wüllner U, Wagner M, Klockgether T, Minnerop M. Reply to: Cognitive dysfunction in spinocerebellar ataxia type 3: variable topographies and patterns. Mov Disord. 2014;29(1): 157-8 (Impact(2014)=5.68, Typ=Comment; Letter; Letter)

Nagtegaal GJ, Pohl C, Wattjes MP, Hulst HE, Freedman MS, Hartung HP, Miller D, Montalban X, Kappos L, Edan G, Pleimes D, Beckman K, Stemper B, Polman CH, Sandbrink R, Barkhof F. Interferon beta-1b reduces black holes in a randomised trial of clinically isolated syndrome. Mult Scler. 2014;20(2): 234-42 (Impact (2014)=4.822, Typ=Journal Article; Clinical Trial, Phase III; Randomized Controlled Trial; Multicenter Study; Research Support, Non-U.S. Gov't; Article)

Sharma M, Wenning G, Krüger R, European Multiple-System Atrophy Study Group (EMSA-SG) , Sharma M, Lichtner P, Albanese A, Barone P, Berciano J, Bloem BR, Coelho M, Goldwurm S, Infante J, Klockgether T, Ortega-Cubero S, Del Sorbo F, Pezzoli G, Canesi M, Tesei S, Zecchinelli A, Sacilotto G, Meucci N, Mariani C, Cilia R, Zini M, Siri C, Pellecchia MT, Picillo M, Amboni M, Schulte C, Martí MJ, Sampaio C, Ferreira J, Levin J, Nilsson CF, Widner H, Østergaard K, Oertel W, Pastor P, Storch A, Seppi K, Geser F, Krismer F, Mahlknecht P, Sprenger FS, Schöls L, Tolosa E, Wüllner U, van de Warrenburg BP, Poewe W, Gasser T, Wenning G, Krüger R. Mutant COQ2 in multiple- system atrophy. N Engl J Med. 2014;371(1): 80-1 (Impact(2014)=55.873, Typ=Comment; Letter; Letter)

Delekate A, Füchtemeier M, Schumacher T, Ulbrich C, Foddis M, Petzold GC. Metabotropic P2Y1 receptor signalling mediates astrocytic hyperactivity in vivo in an Alzheimer's disease mouse model. Nat Commun. 2014;5: 5422 (Impact(2014)=11.47, Typ=Journal Article; Research Support, Non-U.S. Gov't; Article)

Gockel I, Becker J, Wouters MM, Niebisch S, Gockel HR, Hess T, Ramonet D, Zimmermann J, Vigo AG, Trynka G, de León AR, de la Serna JP, Urcelay E, Kumar V, Franke L, Westra HJ, Drescher D, Kneist W, Marquardt JU, Galle PR, Mattheisen M, Annese V, Latiano A, Fumagalli U, Laghi L, Cuomo R, Sarnelli G, Müller M, Eckardt AJ, Tack J, Hoffmann P, Herms S, Mangold E, Heilmann S, Kiesslich R, von Rahden BH, Allescher HD, Schulz HG, Wijmenga C, Heneka MT, Lang H, Hopfner KP, Nöthen MM, Boeckxstaens GE, de Bakker PI, Knapp M, Schumacher J. Common variants in the HLA-DQ region confer susceptibility to idiopathic achalasia. Nat Genet. 2014;46(8): 901-4 (Impact(2014)=29.352, Typ=Journal Article; Research Support, Non-U.S. Gov't; Article)

Heneka MT, Kummer MP, Latz E. Innate immune activation in neurodegenerative disease. Nat Rev Immunol. 2014;14(7): 463-77 (Impact (2014)=34.985, Typ=Review; Journal Article; Review; Research Support, Non-U.S. Gov't; Review)

Hutterer M, Nowosielski M, Haybaeck J, Embacher S, Stockhammer F, Gotwald T, Holzner B, Capper D, Preusser M, Marosi C, Oberndorfer S, Moik M, Buchroithner J, Seiz M, Tuettenberg J, Herrlinger U, Wick A, Vajkoczy P, Stockhammer G. A single-arm phase II Austrian/German multicenter trial on continuous daily sunitinib in primary glioblastoma at first recurrence (SURGE 01-07). Neuro-oncol. 2014;16(1): 92-102 (Impact(2014)=6.776, Typ=Journal Article; Multicenter Study; Clinical Trial, Phase II; Research Support, Non-U.S. Gov't; Article)

Thelen M, Razquin C, Hernandez I, Gorostidi A, Sanchez-Valle R, Ortega-Cubero S, Wolfsgruber S, Drichel D, Fliessbach K, Duenkel T, Damian M, Heilmann S, Slotosch A, Lennarz M, Seijo-Martinez M, Rene R, Kornhuber J, Peters O, Luckhaus C, Jahn H, Hull M, Ruther E, Wiltfang J, Lorenzo E, Gascon J, Lleo A, Llado A, Campdelacreu J, Moreno F, Ahmadzadehfar H, Fortea J, Indakoetxea B, Heneka MT, Wetter A, Pastor MA, Riverol M, Becker T, Frolich L, Tarraga L, Boada M, Wagner M, Jessen F, Maier W, Clarimon J, de Munain AL, Ruiz A, Pastor P, Ramirez A, Ramirez A, Dementia Genetics Spanish Consorti. Investigation of the role of rare TREM2 variants in frontotemporal dementia subtypes Neurobiol Aging. 2014;35(11): 2657.e13- (Impact(2014)=5.013, Typ=Article)

Li ZX, Lu CZ, Zhang XH, Cui LY, Xu XH, Radue E, Chu SG, Wang LR, Beckmann K, Lampe J, Pohl C, Stemper B, Sandbrink R. Interferon beta-1b is effective and has a favourable safety profile in Chinese patients with relapsing forms of multiple sclerosis Neurol Asia. 2014;19(2): 179-189 (Impact(2014)=0.162, Typ=Article)

Yue X, Hariri DJ, Caballero B, Zhang S, Bartlett MJ, Kaut O, Mount DW, Wüllner U, Sherman SJ, Falk T. Comparative study of the neurotrophic effects elicited by VEGF-B and GDNF in preclinical in vivo models of Parkinson's disease. Neuroscience. 2014;258: 385-400 (Impact(2014)=3.357, Typ=Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural; Comparative Study; Article)

Coenen VA, Allert N, Paus S, Kronenbürger M, Urbach H, Mädler B. Modulation of the cerebello-thalamo-cortical network in thalamic deep brain stimulation for tremor: a diffusion tensor imaging study. Neurosurgery. 2014;75(6): 657-69; discussion 669-70 (Impact(2014)=3.62, Typ=Journal Article; Article)

Flock A, Kornblum C, Hammerstingl C, Claeys KG, Gembruch U, Merz WM. Progressive Cardiac Dysfunction in Bethlem Myopathy During Pregnancy Obstet Gynecol. 2014;123 2(2): 436-438 (Impact(2014)=5.175, Typ=Article)

Mack F, Schäfer N, Kebir S, Stuplich M, Schaub C, Niessen M, Scheffler B, Herrlinger U, Glas M. Carmustine (BCNU) plus Teniposide (VM26) in recurrent malignant glioma. Oncology. 2014;86(5-6): 369-72 (Impact(2014)=2.422, Typ=Journal Article; Article)

Getts DR, Terry RL, Getts MT, Deffrasnes C, Müller M, van Vreden C, Ashhurst TM, Chami B, McCarthy D, Wu H, Ma J, Martin A, Shae LD, Witting P, Kansas GS, Kühn J, Hafezi W, Campbell IL, Reilly D, Say J, Brown L, White MY, Cordwell SJ, Chadban SJ, Thorp EB, Bao S, Miller SD, King NJ. Therapeutic inflammatory monocyte modulation using immune-modifying microparticles. Sci Transl Med. 2014;6(219): 219ra7 (Impact(2014)=15.843, Typ=Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural; Article)

Kleinberger G, Yamanishi Y, Suárez-Calvet M, Czirr E, Lohmann E, Cuyvers E, Struyfs H, Pettkus N, Wenninger-Weinzierl A, Mazaheri F, Tahirovic S, Lleó A, Alcolea D, Fortea J, Willem M, Lammich S, Molinuevo JL, Sánchez-Valle R, Antonell A, Ramirez A, Ramirez A, Heneka MT, Sleegers K, van der Zee J, Martin JJ, Engelborghs S, Demirtas-Tatlidede A, Zetterberg H, Van Broeckhoven C, Gurvit H, Wyss-Coray T, Hardy J, Colonna M, Haass C. TREM2 mutations implicated in neurodegeneration impair cell surface transport and phagocytosis. Sci Transl Med. 2014;6(243): 243ra86 (Impact(2014)=15.843, Typ=Journal Article; Research Support, Non-U.S. Gov't; Article)

Boström JP, Seifert M, Greschus S, Schäfer N, Glas M, Lammering G, Herrlinger U. Bevacizumab treatment in malignant meningioma with additional radiation necrosis. An MRI diffusion and perfusion case study. Strahlenther Onkol. 2014;190(4): 416-21 (Impact(2014)=2.914, Typ=Journal Article; Case Reports; Article)

Golla H, Ale Ahmad M, Galushko M, Hampl J, Maarouf M, Schroeter M, Herrlinger U, Hellmich M, Voltz R. Glioblastoma multiforme from diagnosis to death: a prospective, hospital-based, cohort, pilot feasibility study of patient reported symptoms and needs. Support Care Cancer. 2014;22(12): 3341-52 (Impact(2014)=2.364, Typ=Journal Article; Research Support, Non-U.S. Gov't; Article)